SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High-Grade Gliomas: A Multicenter, Open-Label Phase I Study
SYHA1813(一种 VEGFR 和 CSF1R 抑制剂)治疗复发性高级别胶质瘤患者:一项多中心、开放标签的 I 期研究
期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.70166
Kang, Zhuang; Li, Shenglan; Wang, Liang; Chen, Qianxue; Hu, Weiguo; Lei, Ting; Mao, Ying; Zhang, Jing; Xiang, Xiaojun; Wang, Qiming; He, Zhengwen; Sun, Tao; Wang, Yulei; Huang, Mengqian; Zhang, Rong; Chen, Feng; Li, Wenbin